<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmacognosy Res</journal-id><journal-id journal-id-type="iso-abbrev">Pharmacognosy Res</journal-id><journal-id journal-id-type="publisher-id">PR</journal-id><journal-title-group><journal-title>Pharmacognosy Research</journal-title></journal-title-group><issn pub-type="ppub">0976-4836</issn><issn pub-type="epub">0974-8490</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5424553</article-id><article-id pub-id-type="publisher-id">PR-9-133</article-id><article-id pub-id-type="doi">10.4103/0974-8490.204644</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Antiprotozoal Activities of Tiliroside and other Compounds from <italic>Sphaeralcea angustifolia</italic> (Cav.) G. Don</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Calzada</surname><given-names>Fernando</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Basurto</surname><given-names>Jose Correa</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Barbosa</surname><given-names>Elizabeth</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Vel&#x000e1;zquez</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="aff4">3</xref></contrib><contrib contrib-type="author"><name><surname>Hern&#x000e1;ndez</surname><given-names>Normand Garc&#x000ed;a</given-names></name><xref ref-type="aff" rid="aff5">4</xref></contrib><contrib contrib-type="author"><name><surname>Ordo&#x000f1;ez Razo</surname><given-names>R. M.</given-names></name><xref ref-type="aff" rid="aff5">4</xref></contrib><contrib contrib-type="author"><name><surname>Luna</surname><given-names>David Mendez</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Mulia</surname><given-names>Lilian Yepez</given-names></name><xref ref-type="aff" rid="aff6">5</xref></contrib></contrib-group><aff id="aff1">Medical Research Unit in Pharmacology, UMAE Speciality Hospital-2&#x000b0; Floor CORCE National Medical Center Siglo XXI, IMSS, Av. Cuauhtemoc 330, Col. Doctores, CP 06725, M&#x000e9;xico City, M&#x000e9;xico</aff><aff id="aff2"><label>1</label>Laboratory of Molecular Modeling and Bioinform&#x000e1;tics &#x00026; Drug Design, Superior School of Medicine of IPN, Plan de San Luis y D&#x000ed;az Mir&#x000f3;n s/n, 11340 M&#x000e9;xico City, M&#x000e9;xico</aff><aff id="aff3"><label>2</label>Postgraduate Studies and Research, Superior School of Medicine of IPN, Plan de San Lu&#x000ed;s y D&#x000ed;az Mir&#x000f3;n, CP 11340, M&#x000e9;xico City, M&#x000e9;xico</aff><aff id="aff4"><label>3</label>Institute of Health Sciences, Autonomous University of the State of Hidalgo, Km. 4.5 Carretera Pachuca-Tulancingo, Unidad Universitaria, C. P. 42076 Pachuca, Hidalgo, M&#x000e9;xico</aff><aff id="aff5"><label>4</label>Medical Research Unit in Human Genetics UMAE Pediatric Hospital, Medical Center Siglo XXI, IMSS, M&#x000e9;xico</aff><aff id="aff6"><label>5</label>Medical Research Unit in Infectious and Parasitic Diseases UMAE Pediatric Hospital, Medical Center Siglo XXI, IMSS, M&#x000e9;xico</aff><author-notes><corresp id="cor1"><bold>Correspondence:</bold> Dr. Fernando Calzada, Unidad de Investigacion Medica en Farmacologia-2&#x000b0; piso CORCE, Centro Medico Nacional Siglo XXI, IMSS, Av. Cuauhtemoc 330, Col. Doctores, CP 06725, M&#x000e9;xico. E-mail: <email xlink:href="fercalber10@gmail.com">fercalber10@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Apr-Jun</season><year>2017</year></pub-date><volume>9</volume><issue>2</issue><fpage>133</fpage><lpage>137</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2017 Pharmacognosy Research</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p><italic>Sphaeralcea angustifolia</italic> (Malvaceae) is extensively used in Mexican traditional medicine for the treatment of gastrointestinal disorders such as diarrhea and dysentery.</p></sec><sec id="st2"><title>Objective:</title><p>The current study was to validate the traditional use of <italic>S. angustifolia</italic> for the treatment of diarrhea and dysentery on biological grounds using <italic>in vitro</italic> antiprotozoal activity and computational experiments.</p></sec><sec id="st3"><title>Materials and Methods:</title><p>The ethanol extract, subsequent fractions, flavonoids, phenolic acids, and a sterol were evaluated on <italic>Entamoeba histolytica</italic> and <italic>Giardia lamblia</italic> trophozoites. Moreover, molecular docking studies on tiliroside were performed; it was tested for its affinity against pyruvate:ferredoxin oxidoreductase (PFOR) and fructose-1,6-bisphosphate aldolase (G/FBPA), two glycolytic enzymes of anaerobic protozoa.</p></sec><sec id="st4"><title>Results:</title><p>Bioassay-guided fractionation of extract of the aerial parts of <italic>S. angustifolia</italic> gives tiliroside and apigenin, caffeic acid, protocatechuic acid, and &#x003b2;-sitosterol. The <italic>in vitro</italic> antiprotozoal assay showed that tiliroside was the most potent antiprotozoal compound on both protozoa with 50% inhibitory concentration values of 17.5 &#x003bc;g/mL for <italic>E. histolytica</italic> and 17.4 &#x003bc;g/mL for <italic>G. lamblia</italic>. Molecular docking studies using tiliroside showed its probable antiprotozoal mechanism with PFOR and G/FBPA. In both cases, tiliroside showed high affinity and inhibition constant theoretic for PFOR (lowest free binding energy from &#x02212;9.92 kcal/mol and 53.57 &#x003bc;M, respectively) and G/FBPA (free binding energy from &#x02212;7.17 kcal/mol and 55.5 &#x003bc;M, respectively), like to metronidazole, revealing its potential binding mode at molecular level.</p></sec><sec id="st5"><title>Conclusion:</title><p>The results suggest that tiliroside seems to be a potential antiprotozoal compound responsible for antiamoebic and antigiardial activities of <italic>S. angustifolia</italic>. Its <italic>in vitro</italic> antiprotozoal activities are in good agreement with the traditional medicinal use of <italic>S. angustifolia</italic> in gastrointestinal disorders such as diarrhea and dysentery.</p></sec><sec id="st6"><title>SUMMARY</title><p>Bioassay-guided fractionation of extract of the aerial parts of <italic>S. angustifolia</italic> gives: tiliroside and apigenin, caffeic acid, protocatechuic acid) and &#x003b2;-sitosterol. The <italic>in vitro</italic> antiprotozoal assay showed that tiliroside was the most potent antiprotozoal compound on both protozoa with IC50 values of 17.5 mg/mL for <italic>E. histolytica</italic> and 17.4 &#x003bc;g/mL for <italic>G. lamblia</italic>. Molecular docking studies using tiliroside showed its probable antiprotozoal mechanism with PFOR and <italic>G</italic>/FBPA. In both cases tiliroside showed high affinity and inhibition constant theoretic for PFOR (lowest free binding energy from -9.92 kcal/mol and 53.57 mM, respectively) and G/FBPA (free binding energy from -7.17 kcal/mol, respectively and 55.5 &#x003bc;M), like to metronidazole, revealing its potential binding mode at molecular level. The results suggest that tiliroside seems to be a potential antiprotozoal compound responsible for antiamoebic and antigiardial activities of <italic>Sphaeralcea angustifolia</italic>.</p><p><inline-graphic xlink:href="PR-9-133-g001.jpg"/></p><p><bold>Abbreviations Used:</bold> PFOR: Pyruvate:ferredoxin oxidoreductase; G/FBPA: Fructose 1,6 bisphosphate aldolase.</p></sec></abstract><kwd-group><title>Key words</title><kwd>Antiprotozoal activity</kwd><kwd>gastrointestinal disorders</kwd><kwd>fructose-1</kwd><kwd>6-bisphosphate aldolase</kwd><kwd>molecular docking</kwd><kwd>pyruvate:ferredoxin oxidoreductase</kwd><kwd><italic>Sphaeralcea angustifolia</italic></kwd><kwd>tiliroside</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>The anaerobic protozoa <italic>Entamoeba histolytica</italic> and <italic>Giardia lamblia</italic> collectively infect over one billion people each year. Both are pathogens of the intestinal tract of humans; the first causes were dysentery, liver abscess, and invade other organs; the second causes were intestinal malabsorption, bloating, nausea, loss of appetite, vomiting, and severe diarrhea. These enteric parasitic infections are a health problem in the world, particularly in developing countries where there are poor sanitary conditions.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref>] In Mexico, amoebiasis is an endemic disease, with incidence rates that vary among the geographic regions of the country. In the last 7 years, it has been a serious health problem, and it was the 10<sup>th</sup> cause of morbidity among all age groups. In the case of giardiasis, it currently accounts for an estimated nine millions of sick each year, and it is the leading cause of intestinal parasitosis of medical importance in children.[<xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref>]</p><p>Treatments with antiprotozoal drugs as metronidazole, tinidazole, iodoquinol, diloxanide furoate, and paromomycin fail at a rate of ~20%. In the case of metronidazole, it is the drug of choice currently used in Mexico for the treatment of infections caused by <italic>G. lamblia</italic> and <italic>E. histolytica</italic>. It is effective; however, it is mutagenic in bacteria and carcinogenic in rodents. In addition, this drug has several other side effects including gastrointestinal disturbance, especially nausea and vomiting. Furthermore, infrequent adverse effects include headache and stomatitis. In long-term systemic treatment, patients experience dry mouth, metallic taste, headache, and vertigo. Moreover, it is associated with the development of leukopenia, neutropenia, and central nervous system toxicity. In addition, clinical and laboratory-generated resistant strains of both protozoa have been reported.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref>] Clearly, there are needs for alternative antiamoebic and antigiardial agents. In this sense, many plants species are used in Mexican traditional medicine for the treatment of diarrhea and dysentery; these plants should be analyzed to determine their efficacy and thus their potential as sources of new antiprotozoal drugs.</p><p><italic>Sphaeralcea angustifolia</italic> (Cav.) G. Don (Malvaceae) is an erect perennial plant of 0.5&#x02013;2 m of height, densely stellate-pubescent throughout with grayish or slightly yellowish hairs; the gray-green leaf blades are lanceolate to lance-oblong, cuneate at base, margin usually finely and regularly crenate. The leafy inflorescence bears have several flowers each one with five wedge-shaped mauve or lavender petals. It is widely distributed in the USA and Mexico; it grows in desert and plateau habitat. <italic>S. angustifolia</italic> is commonly known as &#x0201c;Copper Globemallow&#x0201d; in the USA, while in Mexico, it is locally called &#x0201c;Hierba del negro and Vara de San Jos&#x000e9;.&#x0201d; In Mexican traditional medicine, the leaves from <italic>S. angustifolia</italic> are used for the treatment of inflammatory disorders such as rheumatism, inflamed skin, and arthritis. In addition, they are used for the treatment of diseases of the gastrointestinal tract as abdominal pain, diarrhea, and dysentery.[<xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref13" ref-type="bibr">13</xref>]</p><p>Previous pharmacological investigations reported the utility for the treatment in hand osteoarthritis and anti-inflammatory properties of this plant. Scopoletin, tomentin, and sphaeralcic acid were thought to be responsible for anti-inflammatory properties of <italic>S. angustifolia</italic>. In addition, &#x003b2;-sitosterol, stigmasterol, &#x003b1;- and &#x003b2;-amyrins, and transcinnamic acid have been isolated of this plant.[<xref rid="ref14" ref-type="bibr">14</xref><xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref18" ref-type="bibr">18</xref>] On the other hand, intraperitoneal administration of the dichloromethane extract in rodents did not indicate severe systematic toxicity, adverse effects, hematological or biochemical alterations.[<xref rid="ref16" ref-type="bibr">16</xref>]</p><p>Despite the traditional medicinal use of <italic>S. angustifolia</italic>, no data are available with respect to its usefulness in gastrointestinal disorders caused by protozoa such as diarrhea and dysentery. Therefore, the aim of this study was to examine the effects of the ethanol extract, fractions, and pure compounds obtained from the aerial parts of <italic>S. angustifolia</italic> using <italic>in vitro</italic> antiprotozoal activity and computational experiments, so as to assess some of the possible mechanisms involved in the traditional use.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><sec id="sec2-1"><title>Plant material</title><p>The aerial parts of <italic>S. angustifolia</italic> were collected from La Conchita-Zapotitlan, Tl&#x000e1;huac, Ciudad de M&#x000e9;xico (Mexico), in March 2012 by Dr. Fernando Calzada. Sample was authenticated by MS Abigail Aguilar-Contreras of Instituto Mexicano del Seguro Social (IMSS), Mexico. Specimen having voucher no. 15794 was deposited in the Herbarium IMSSM of IMSS.</p></sec><sec id="sec2-2"><title>Extraction from <italic>Sphaeralcea angustifolia</italic></title><p>The air-dried and finely powdered aerial parts (600 g) were extracted by maceration at room temperature with EtOH (5 times &#x000d7; 20 L). After filtration, the extract was combined and evaporated <italic>in vacuo</italic> to yield 80 g of green residue.</p></sec><sec id="sec2-3"><title>Isolation of antiprotozoal compounds from the ethanol extract of <italic>Sphaeralcea angustifolia</italic></title><p>A portion of crude ethanol extract (30 g) was suspended in methanol-water (50 mL; 5:45) and fractionated into chloroform fraction (11.8 g, 100 mL &#x000d7; 2 times), ethyl acetate fraction (0.80 g, 100 mL &#x000d7; 2 times), and the aqueous residual fraction (AR, 17.4 g). 10 g of chloroform fraction was subjected to a silica gel column chromatography (CC, 167 g 70&#x02013;230 mesh, E. Merck, Germany) and eluted with chloroform (100%), chloroform-methanol (90:10; v/v), chloroform-methanol (80:20; v/v), and chloroform-methanol (70:30; v/v) to give three fractions: Fr1 (1.5 L), Fr2 (0.5 L), and Fr3 (1. 3 L). From Fraction 1, &#x003b2;-sitosterol (1, 1.58 g) crystallized spontaneously. From Fraction 2, tiliroside (2, 400 mg) crystallized spontaneously. Fraction 3 (115 mg) was purified by preparative thin-layer chromatography (TLC) (25 mg each plate &#x000d7; 5; silica gel Merck; EtOAc-MeOH-water, 100: 16.5: 13.5) to give caffeic acid (3, 15.5 mg), protocatechuic acid (4, 12 mg), apigenin (5, 11.7 mg), and additional amounts of tiliroside (27.5 mg). The structure of pure compounds 1&#x02013;5 was ascertained by physical and spectroscopic properties (MP, TLC, HPLC, and RMN) compared with those reported in the literature and authentic samples (Sigma) available in our laboratory.</p></sec><sec id="sec2-4"><title>Antiprotozoal assays</title><p><italic>E. histolytica</italic> strain HM1-IMSS used in all experiments was grown axenically at 37&#x000b0;C in TYI-S-33 medium supplemented with 10% heat-inactivated bovine serum. In the case of <italic>G. lamblia</italic>, strain IMSS: 8909:1 was grown in TYI-S-33 modified medium supplemented with 10% calf serum and bovine bile. The trophozoites were axenically maintained and for assays were employed in the log phase of growth. <italic>In vitro</italic> susceptibility tests were performed using a subculture method previously described.[<xref rid="ref19" ref-type="bibr">19</xref>] Briefly, <italic>E. histolytica</italic> (6 &#x000d7; 10<sup>3</sup>) or <italic>G. lamblia</italic> (5 &#x000d7; 10<sup>4</sup>) trophozoites were incubated for 48 h at 37&#x000b0;C in the presence of different concentrations (2.5&#x02013;200 &#x003bc;g/mL) of the crude extract or pure compounds in dimethyl sulfoxide (DMSO). Each test included metronidazole (Sigma) as standard amoebicidal and giardicidal drugs, a control (culture medium plus trophozoites and DMSO), and a blank (culture medium). After incubation, the trophozoites were detached by chilling and 50 &#x003bc;L samples of each tube were subcultured in fresh medium for another 48 h, without antiprotozoal samples. The final number of parasites was determined with an hemocytometer, and the percentages of trophozoites growth inhibition were calculated by comparison with the control culture. The results were confirmed by a colorimetric method: The trophozoites were washed and incubated for 45 min at 37&#x000b0;C in phosphate buffer saline with 3-<xref rid="ref4" ref-type="bibr">4</xref>5-dimethylhiazol-2-il]-2,5-diphenyl tetrazolium bromide and phenazine methosulfate. The dye produced (formazan) was extracted and the absorbance was determined at 570 nm. The experiments were performed in duplicate for each protozoan and repeated at least three times. Data were analyzed using probit analysis.[<xref rid="ref20" ref-type="bibr">20</xref>] The <italic>in vitro</italic> results were classified as follows: If the samples displayed a 50% inhibitory concentration (IC<sub>50</sub>) &#x0003c;20.0 &#x003bc;g/mL, the antiprotozoal activity was considered good; from 21.0 to 60 &#x003bc;g/mL, the antiprotozoal activity was considered moderate; from 61 to 200 &#x003bc;g/mL, the antiprotozoal activity was considered weak; and over 200 &#x003bc;g/mL, the samples were considered inactive.</p></sec><sec id="sec2-5"><title>Statistical analysis</title><p>Data were analyzed using probit analysis. The percentage of trophozoites surviving was calculated by comparison with the growth in the control group. The plot of probit against log concentration was made, the best straight line was determined by regression analysis, and the IC<sub>50</sub> values were calculated. The regression coefficient, its level of significance (<italic>P</italic> &#x0003c; 0.05 indicates significant difference between group), and correlation coefficient were calculated and 95% confidence interval (CI) values determined.[<xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref22" ref-type="bibr">22</xref><xref rid="ref23" ref-type="bibr">23</xref>]</p></sec><sec id="sec2-6"><title>Computational study</title><p>Considering that enzymes pyruvate:ferredoxin oxidoreductase (PFOR) and G/FBPA are two potential targets for drug design in anaerobic pathogens as <italic>E. histolytica</italic> and <italic>G. lamblia</italic> and that both are target of inhibitor metronidazole, we decide test tiliroside <italic>in silico</italic>.[<xref rid="ref24" ref-type="bibr">24</xref><xref rid="ref25" ref-type="bibr">25</xref>] Furthermore, to known the potential binding mode at molecular level of tiliroside 2 as antiprotozoal agent, it was compared versus metronidazole in molecular docking experiments. We carried out docking studies employing two glycolytic enzymes as potential targets, PFOR and G/FBPA from <italic>Desulfovibrio africanus</italic> and <italic>G. lamblia</italic>, respectively.[<xref rid="ref26" ref-type="bibr">26</xref><xref rid="ref27" ref-type="bibr">27</xref><xref rid="ref28" ref-type="bibr">28</xref>] Briefly, the crystal structures were retrieved from RCSB (PDB IDs: 1KEK and 3GAY, respectively); total molecules of water and ions no needed to catalytic activity were stripped to preserve the entire protein. Subsequently, ligands structures (tiliroside and metronidazole) were drawn with ChemBioDraw Ultra 11.0 software. Then, the complete optimization of geometry and energy before docking simulations was done with Gaussian 09 package; the output minimized structures were converted into input files to docking with GaussView 5.0. Docking simulations were conducted with AutoDock 4.2 applying the follow search parameters: Total Kollman charges were computed after polar hydrogen atoms were added in such atoms from the residues with capability to establish H bonds; a blind docking procedure was conducted in all the simulations with a grid box of 126 &#x000c5; &#x000d7;126 &#x000c5; &#x000d7; 126 &#x000c5; in each space coordinates establishing a spacing in each grid point of 0.375 &#x000c5;; the scoring function selected was the Lamarckian genetic algorithm with a randomized initial population of 100 individuals delimiting a total of 1 &#x000d7; 10<sup>7</sup> cycles such as maximum number of energy evaluations. Resulting docking orientations within 1.0 &#x000c5; in the root-mean-square deviation tolerance of each other were clustered together and represented by the result with the most favorable free energy of binding. Nonbonded interactions were analyzed with PyMOL graphical viewer. AutoDock 4.2 is currently being distributed free of charge as open source under a GPL license at the WWW site: <ext-link ext-link-type="uri" xlink:href="http://autodock.scripps.edu">http://autodock.scripps.edu</ext-link>. ADT is being distributed free of charge as part of the MGLTools package, at the WWW site: <ext-link ext-link-type="uri" xlink:href="http://mgltools.scripps.edu/downloads">http://mgltools.scripps.edu/downloads</ext-link>. AutoDock &#x00026; this web site are Copyright &#x000a9; 1989-2017 The Scripps Research Institute. All Rights Reserved.</p></sec></sec><sec id="sec1-3"><title>RESULTS AND DISCUSSION</title><p><italic>S. angustifolia</italic> is used in Mexican traditional medicine for the treatment of gastrointestinal diseases, including diarrhea and dysentery, as well inflammatory disorders.[<xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref13" ref-type="bibr">13</xref>] In the present work as part our research to obtain potential antiprotozoal agents by medicinal plants and to rationalize their traditional use in Mexican traditional medicine the bioassay-guided fractionation of the active ethanol extract of the aerial parts of <italic>S. angustifolia</italic> against <italic>E. histolytica</italic> and <italic>G. lamblia</italic> was performed. Bioassay-guided fractionation of the active ethanol extract of the aerial parts of <italic>S. angustifolia</italic> against <italic>E. histolytica</italic> and G. lambli a was performed [<xref ref-type="table" rid="T1">Table 1</xref>]. The ethanol extract was fractionated into organic and aqueous soluble fractions by organic solvent extractions with CHCl<sub>3</sub> and EtOAc. All fractions (CHCl<sub>3</sub>, EtOAc, and AR) were tested for antiprotozoal activity using <italic>E. histolytica</italic> and <italic>G. lamblia</italic> trophozoites. As a result of this process, chloroform fraction showed the best inhibitory activity on both protozoa; it was purified by CC to give two flavonoids (tiliroside 2 and apigenin 5), two phenolic acids (caffeic acid 3 and protocatechuic acid 4), and a sterol (&#x003b2;-sitosterol 1). In addition, the ethyl acetate and the aqueous residual fractions were discarded because they showed weak activity against both protozoa.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Antiprotozoal activity of the ethanol extract, fractions, and pure compounds obtained of the aerial parts of <italic>Sphaeralcea angustifolia</italic><sup>a</sup></p></caption><graphic xlink:href="PR-9-133-g002"/></table-wrap><p>The antiprotozoal activities of all isolated compounds in this work were tested on <italic>E. histolytica</italic> and <italic>G. lamblia</italic> trophozoites [<xref ref-type="table" rid="T1">Table 1</xref>]. Among these, tiliroside 2 was the most potent compound on both protozoa with IC<sub>50</sub> values of 17.5 &#x003bc;g/mL for <italic>E. histolytica</italic> and 17.4 &#x003bc;g/mL for <italic>G. lamblia</italic>. Apigenin showed selectivity against <italic>G. lamblia</italic> (IC<sub>50</sub> 10.1 &#x003bc;g/mL). The remaining compounds tested showed moderate or weak activity. All compounds were less active than metronidazole, drug used as positive control. To the best of our knowledge, this is the first report of antiamoebic and antigiardial properties of compounds 3 and 4. Further, this is the first bioassay-guided work to obtain the antiprotozoal compounds of the aerial parts of <italic>S. angustifolia</italic>. Tiliroside 2 is a flavonoid isolated from several medicinal plants with important <italic>in vivo</italic> and <italic>in vitro</italic> antiprotozoal activity. In this sense, it has been speculated that antidiarrheic properties of medicinal plants are a consequence of their inhibitory actions on protozoa.[<xref rid="ref29" ref-type="bibr">29</xref><xref rid="ref30" ref-type="bibr">30</xref>] In addition, tiliroside which was obtained in a large amount may be a prodrug of kaempferol considering that flavonoid glycosides are hydrolyzed by intestinal bacteria, cell-free extract from the small intestine, or gastrointestinal fluid.[<xref rid="ref31" ref-type="bibr">31</xref><xref rid="ref32" ref-type="bibr">32</xref><xref rid="ref33" ref-type="bibr">33</xref><xref rid="ref34" ref-type="bibr">34</xref>] In this context, kaempferol is a flavonoid with significant <italic>in vitro</italic> and <italic>in vivo</italic> antiprotozoal activity; then, it may contribute to the observed antiprotozoal activity of the aerial parts of <italic>S. angustifolia</italic>. The antiprotozoal activity of tiliroside is in agreement with the results published by the author's group and confirms that it flavonoid glycoside may be a leading compound in the development of novel antiamoebic and antigiardial drugs.[<xref rid="ref29" ref-type="bibr">29</xref><xref rid="ref30" ref-type="bibr">30</xref>]</p><p>In relation with the molecular docking experiments, they are based on the fact that genome studies have recently contributed to the discovery of a new array of virulence determinants in pathogenic protozoa as <italic>E. histolytica</italic>, as well as identification of novel drug candidates.[<xref rid="ref24" ref-type="bibr">24</xref><xref rid="ref25" ref-type="bibr">25</xref><xref rid="ref35" ref-type="bibr">35</xref>] However, no data are available that explain its potential binding mode at molecular level. In this regard, <italic>in silico</italic> approaches has been applied to search the possible interaction between the potential targets and molecules obtained from natural products as flavonoids yielding new pharmacological horizons.[<xref rid="ref36" ref-type="bibr">36</xref><xref rid="ref37" ref-type="bibr">37</xref><xref rid="ref38" ref-type="bibr">38</xref>] In the present study, results obtained from <italic>in vitro</italic> and <italic>in silico</italic> experiments yield important findings of the possible inhibition activity of tiliroside over two enzymes involved in the glycolytic pathway of anaerobic protozoa. In specific, tiliroside [<xref ref-type="fig" rid="F1">Figure 1</xref>] docked over PFOR, it showed interactions with 14 amino acids residues (Ala 117 [at 2.99 &#x000c5;], Ala 118 [at 2.16 &#x000c5;], Leu 121 [at 3.10 &#x000c5;], Phe 665 [at 2.74 &#x000c5;], Leu 667 [at 3.55 &#x000c5;], Gly 845 [at 2.10 &#x000c5;], Ala 845 [at 4.10 &#x000c5;], Met 851 [at 4.17 &#x000c5;], Pro 852 [at 2.89 &#x000c5;], Tyr 853 [at 3.94 &#x000c5;], Trp 864 [at 3.28 &#x000c5;], Gly 865 [at 3.29 &#x000c5;], Asn 866 [at 3.91 &#x000c5;], and Tyr 875 [at 3.90 &#x000c5;]) in a region different that metronidazole; the interactions were established downstream of the iron-sulfur cluster forming mainly H-bond interactions according to its chemical nature [<xref ref-type="fig" rid="F2">Figure 2</xref>, lower right panel]. In contrast, metronidazole (Phe 174 [at 3.25 &#x000c5;], His 178 [at 3.33 &#x000c5;], Lys 435 [at 2.83 &#x000c5;], Phe 453 [at 3.24 &#x000c5;], and Tyr 455 [at 2.90 &#x000c5;]) showed a binding posed most closed to iron-sulfur cluster [<xref ref-type="fig" rid="F2">Figure 2</xref>, upper right panel]. In the case of interaction of tiliroside over G/FBPA, it showed a similar behavior in which tiliroside interacted with ten amino acids residues (Pro 2 [at 3.10 &#x000c5;], Leu 3 [at 2.54 &#x000c5;], Lys 63 [at 4.27 &#x000c5;], Cys 66 [at 3.15 &#x000c5;], Glu 67 [at 3.43 &#x000c5;], Leu 70 [at 3.86 &#x000c5;], Glu 71 [at 1.83 &#x000c5;], Ile 80 [at 4.55 &#x000c5;], and Leu 97 [at 4.25 &#x000c5;]) in a place different [<xref ref-type="fig" rid="F3">Figure 3</xref>, upper right panel] that the inhibitor metronidazole [<xref ref-type="fig" rid="F3">Figure 3</xref>, lower right panel]; its interactions were with seven amino acids residues (His 178 [at 2.92 &#x000c5;], Gly 211 [at 2.91 &#x000c5;], Ser 213 [at 2.06 &#x000c5;], Asn 253 [at 3.22 &#x000c5;], Val 254 [at 5.37 &#x000c5;], Asp 255 [at 3.25 &#x000c5;], and Ser 256 [at 4.36 &#x000c5;]), and Zn <sup>2+</sup> (at 2.23 &#x000c5;) atom. Our results showed that tiliroside exhibited high affinities on both glycolytic enzymes with lowest free binding energy from &#x02212;9.92 kcal/mol for PFOR and from &#x02212;7.17 for G/FBPA kcal/mol like to metronidazole (&#x02212;5.09 and &#x02212;10.04 kcal/mol, respectively). In addition, inhibition constant theoretic for PFOR (53.57 &#x003bc;M) and G/FBPA (55.5 &#x003bc;M) was like to metronidazole (47.64 &#x003bc;M and 44.01 &#x003bc;M). In both cases, the results explain the possible mode of interaction of tiliroside with the amino acid environment of the binding site in the PFOR and G/FBPA at molecular level.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Chemical structure of tiliroside 2</p></caption><graphic xlink:href="PR-9-133-g003"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Inhibition sites over pyruvate:ferredoxin oxidoreductase to tiliroside and metronidazole (left panel). Close contact of the binding modes of metronidazole (upper right panel) and tiliroside (lower right panel). H bonds are showed in red dashes. Y = Tyr; W = Trp, G = Gly, N = Asn, L = Leu, M = Met, A = Ala, P = Pro, F = Phe, H = His, K = Lys. SF4= [4Fe-4S] cluster</p></caption><graphic xlink:href="PR-9-133-g004"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Inhibition sites over G/FBPA to metronidazole and tiliroside (left panel). Close contact of the binding modes of metronidazole (lower right panel) in short distance to Zn<sup>2+</sup> atom and tiliroside (upper right panel). H bonds are showed in red dashes. G = Gly, N = Asn; L = Leu, P = Pro, H = His, V = Val, S = Ser, E = Glu, C = Cys, D = Asp, I = Ile, and K = Lys</p></caption><graphic xlink:href="PR-9-133-g005"/></fig><p>Glycolysis is an important metabolic pathway for most organisms, including protozoan parasites such as <italic>E. histolytica</italic> and <italic>G. lamblia</italic>. Many of these primitive eukaryotes have streamlined their metabolism, favoring glycolysis for generating ATP in the glucose-rich environments in which they reside. Therefore, the enzymes involved in glucose metabolisms such as PFOR and G/FBPA could prove to be attractive targets for therapeutic development.[<xref rid="ref26" ref-type="bibr">26</xref><xref rid="ref27" ref-type="bibr">27</xref><xref rid="ref28" ref-type="bibr">28</xref><xref rid="ref29" ref-type="bibr">29</xref><xref rid="ref39" ref-type="bibr">39</xref><xref rid="ref40" ref-type="bibr">40</xref>]</p></sec><sec sec-type="conclusions" id="sec1-4"><title>CONCLUSION</title><p>Results of the present work along with the <italic>in vivo</italic> and <italic>in vitro</italic> antiprotozoal properties previously describes to tiliroside[<xref rid="ref29" ref-type="bibr">29</xref><xref rid="ref30" ref-type="bibr">30</xref>] could suggest that part of the mechanism by which <italic>S. angustifolia</italic> inhibits diarrhea and dysentery involves antigiardial and antiamoebic effects. In this context, the antidiarrheic properties reputed for <italic>S. angustifolia</italic> in Mexican traditional medicine may be due to the presence of flavonoids: tiliroside and apigenin. In addition, in agreement with docking analysis, the antiprotozoal activity of tiliroside on anaerobic protozoa as <italic>E. histolytica</italic> and <italic>G. lamblia</italic> may be through of inhibition of glycolytic enzymes PFOR and G/FBPA. In addition, although tiliroside was less active than metronidazole, it may be of interest to medicinal chemists who are interested in developing new antiprotozoal agents, considering that tiliroside interacted in a region different that metronidazole in the enzymes PFOR and G/FBPA. To confirm the results obtained in computational experiments on the interaction between tiliroside and glycolytic enzymes, proteomic approach based on two-dimensional gel electrophoresis and mass spectrometry (ESI-MS/MS) analysis is in process.[<xref rid="ref41" ref-type="bibr">41</xref>]</p><sec id="sec2-7"><title>Financial support and sponsorship</title><p>We are grateful the research scholarship of IMSS Foundation A.C. given to Dr. Normand Garcia Hernandez.</p></sec><sec id="sec2-8" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ack><title>Acknowledgement</title><p>We thank MS Abigail Aguilar, IMSS Herbarium, for authentication of plant material.</p></ack><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldursson</surname><given-names>S</given-names></name><name><surname>Karanis</surname><given-names>P</given-names></name></person-group><article-title>Waterborne transmission of protozoan parasites: Review of worldwide outbreaks &#x02013; An update 2004-2010</article-title><source>Water Res</source><year>2011</year><volume>45</volume><fpage>6603</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">22048017</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casburn-Jones</surname><given-names>AC</given-names></name><name><surname>Farthing</surname><given-names>MJ</given-names></name></person-group><article-title>Management of infectious diarrhoea</article-title><source>Gut</source><year>2004</year><volume>53</volume><fpage>296</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">14724167</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>MA</given-names></name><name><surname>Khan</surname><given-names>NA</given-names></name><name><surname>Qasmi</surname><given-names>IA</given-names></name><name><surname>Ahmad</surname><given-names>G</given-names></name><name><surname>Zafar</surname><given-names>S</given-names></name></person-group><article-title>Protective effect of Arque-Ajeeb on acute experimental diarrhoea in rats</article-title><source>BMC Complement Altern Med</source><year>2004</year><volume>4</volume><fpage>8</fpage><pub-id pub-id-type="pmid">15238156</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upcroft</surname><given-names>P</given-names></name><name><surname>Upcroft</surname><given-names>JA</given-names></name></person-group><article-title>Drug targets and mechanisms of resistance in the anaerobic protozoa</article-title><source>Clin Microbiol Rev</source><year>2001</year><volume>14</volume><fpage>150</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">11148007</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><source>SS (Secretaria de Salud). Sistema Nacional de Vigilancia Epidemiologica; Epidemiologia 34, semana 34</source><year>2008</year><comment>ISSN 1405-2636</comment></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="webpage"><article-title>Direcci&#x000f3;n General de Epidemiolog&#x000ed;a (DGE)</article-title><source>Anuarios de Morbilidad 2008-2013</source><year>2013</year><date-in-citation>Last accesed on 2017 Dec 12</date-in-citation><comment>Available from: <uri xlink:type="simple" xlink:href="http://www.epidemiologia.salud.gob.mx/anuario/html/anuarios.html">http://www.epidemiologia.salud.gob.mx/anuario/html/anuarios.html</uri></comment></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;ndez</surname><given-names>EG</given-names></name><name><surname>Granados</surname><given-names>J</given-names></name><name><surname>Partida-Rodr&#x000ed;guez</surname><given-names>O</given-names></name><name><surname>Valenzuela</surname><given-names>O</given-names></name><name><surname>Rasc&#x000f3;n</surname><given-names>E</given-names></name><name><surname>Maga&#x000f1;a</surname><given-names>U</given-names></name><etal/></person-group><article-title>Prevalent HLA class II alleles in Mexico City appear to confer resistance to the development of amebic liver abscess</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0126195</fpage><pub-id pub-id-type="pmid">25938667</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="webpage"><collab>Gu&#x000ed;a Pr&#x000e1;ctica Cl&#x000ed;nica (GPC)</collab><article-title>Prevenci&#x000f3;n, diagn&#x000f3;stico y tratamiento farmacol&#x000f3;gico de la giardiasis en ni&#x000f1;os y adolescentes de 1 a 18 a&#x000f1;os en el primer y segundo nivel de atenci&#x000f3;n</article-title><source>Evidencias y recomendaciones. Publicado por CENETEC</source><year>2012</year><date-in-citation>Last accesed on 2017 Dec 12</date-in-citation><comment>Available from: <uri xlink:type="simple" xlink:href="http://www.cenetec.salud.gob.mx/interior/gpc.html">http://www.cenetec.salud.gob.mx/interior/gpc.html</uri></comment></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peraza-S&#x000e1;nchez</surname><given-names>SR</given-names></name><name><surname>Poot-Kant&#x000e2;n</surname><given-names>S</given-names></name><name><surname>Torres-Tapia</surname><given-names>LW</given-names></name><name><surname>May-Pat</surname><given-names>F</given-names></name><name><surname>Sim&#x000e1;-Polanco</surname><given-names>P</given-names></name><name><surname>Cedillo-Rivera</surname><given-names>R</given-names></name></person-group><article-title>Screening of native plants from Yucat&#x000e1;n for anti-<italic>Giardia lamblia</italic> activity</article-title><source>Pharm Biol</source><year>2005</year><volume>43</volume><fpage>594</fpage><lpage>8</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>J</given-names></name><name><surname>R&#x000fc;hle</surname><given-names>G</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>N</given-names></name><name><surname>Rossignol</surname><given-names>JF</given-names></name><name><surname>Hemphill</surname><given-names>A</given-names></name></person-group><article-title><italic>In vitro</italic> effects of thiazolides on <italic>Giardia lamblia</italic> WB clone C6 cultured axenically and in coculture with Caco2 cells</article-title><source>Antimicrob Agents Chemother</source><year>2006</year><volume>50</volume><fpage>162</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">16377682</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behnia</surname><given-names>M</given-names></name><name><surname>Haghighi</surname><given-names>A</given-names></name><name><surname>Komeylizadeh</surname><given-names>H</given-names></name><name><surname>Tabaei</surname><given-names>SJ</given-names></name><name><surname>Abadi</surname><given-names>A</given-names></name></person-group><article-title>Inhibitory effects of Iranian <italic>Thymus vulgaris</italic> extracts on <italic>in vitro</italic> growth of <italic>Entamoeba histolytica</italic></article-title><source>Korean J Parasitol</source><year>2008</year><volume>46</volume><fpage>153</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">18830054</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Aguilar</surname><given-names>A</given-names></name><name><surname>Camacho</surname><given-names>J</given-names></name><name><surname>Chino</surname><given-names>S</given-names></name><name><surname>J&#x000e1;quez</surname><given-names>P</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>ME</given-names></name></person-group><article-title>Herb&#x000e1;rio medicinal del Instituto Mexicano del Seguro Social</article-title><source>Informaci&#x000f3;n Etnobot&#x000e1;nica</source><year>1994</year><edition>1st ed</edition><publisher-loc>M&#x000e9;xico</publisher-loc><publisher-name>IMSS</publisher-name><fpage>140</fpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Argueta</surname><given-names>A</given-names></name><name><surname>Cano</surname><given-names>L</given-names></name><name><surname>Rodarte</surname><given-names>M</given-names></name></person-group><source>Atlas de las Plantas de la Medicina Tradicional Mexicana</source><year>1994</year><volume>Vol. I-III</volume><publisher-loc>Mexico City</publisher-loc><publisher-name>Instituto Nacional Indigenista</publisher-name></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meckes</surname><given-names>M</given-names></name><name><surname>David-Rivera</surname><given-names>AD</given-names></name><name><surname>Nava-Aguilar</surname><given-names>V</given-names></name><name><surname>Jimenez</surname><given-names>A</given-names></name></person-group><article-title>Activity of some Mexican medicinal plant extracts on carrageenan-induced rat paw edema</article-title><source>Phytomedicine</source><year>2004</year><volume>11</volume><fpage>446</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">15330501</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju&#x000e1;rez-Ciriaco</surname><given-names>M</given-names></name><name><surname>Rom&#x000e1;n-Ramos</surname><given-names>R</given-names></name><name><surname>Gonz&#x000e1;lez-M&#x000e1;rquez</surname><given-names>H</given-names></name><name><surname>Meckes-Fischer</surname><given-names>M</given-names></name></person-group><article-title>Efecto de <italic>Sphaeralcea angustifoli</italic> a sobre la expresi&#x000f3;n de citocinas pro y antiinflamatorias</article-title><source>Lab Cienc</source><year>2008</year><volume>2</volume><fpage>21</fpage><lpage>4</lpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Rodr&#x000ed;guez</surname><given-names>RV</given-names></name><name><surname>Chamorro-Cevallos</surname><given-names>G</given-names></name><name><surname>Siordia</surname><given-names>G</given-names></name><name><surname>Jim&#x000e9;nez-Arellanes</surname><given-names>MA</given-names></name><name><surname>Chavez-Soto</surname><given-names>MA</given-names></name><name><surname>Meckes-Fischer</surname><given-names>M</given-names></name></person-group><article-title><italic>Sphaeralcea angustifolia</italic> (Cav.) G. Don extract, potential phytomedicine to treat chronic inflammation</article-title><source>Bol Latinoam Caribe Plant Med Aromat</source><year>2012</year><volume>11</volume><fpage>468</fpage><lpage>77</lpage></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Hern&#x000e1;ndez</surname><given-names>J</given-names></name><name><surname>Gonz&#x000e1;lez-Cortazar</surname><given-names>M</given-names></name><name><surname>Marquina</surname><given-names>S</given-names></name><name><surname>Herrera-Ruiz</surname><given-names>M</given-names></name><name><surname>Meckes-Fischer</surname><given-names>M</given-names></name><name><surname>Tortoriello</surname><given-names>J</given-names></name><etal/></person-group><article-title>Sphaeralcic acid and tomentin, anti-inflammatory compounds produced in cell suspension cultures of <italic>Sphaeralcea angustifolia</italic></article-title><source>Planta Med</source><year>2014</year><volume>80</volume><fpage>209</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">24488717</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero-Cerecero</surname><given-names>O</given-names></name><name><surname>Meckes-Fischer</surname><given-names>M</given-names></name><name><surname>Zamilpa</surname><given-names>A</given-names></name><name><surname>Enrique Jim&#x000e9;nez-Ferrer</surname><given-names>J</given-names></name><name><surname>Nicasio-Torres</surname><given-names>P</given-names></name><name><surname>P&#x000e9;rez-Garc&#x000ed;a</surname><given-names>D</given-names></name><etal/></person-group><article-title>Clinical trial for evaluating the effectiveness and tolerability of topical <italic>Sphaeralcea angustifolia</italic> treatment in hand osteoarthritis</article-title><source>J Ethnopharmacol</source><year>2013</year><volume>147</volume><fpage>467</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">23528365</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calzada</surname><given-names>F</given-names></name><name><surname>Meckes</surname><given-names>M</given-names></name><name><surname>Cedillo-Rivera</surname><given-names>R</given-names></name><name><surname>Tapia-Contreras</surname><given-names>A</given-names></name><name><surname>Mata</surname><given-names>R</given-names></name></person-group><article-title>Screening of Mexican medicinal plants for antiprotozoal activity</article-title><source>Pharm Biol</source><year>1998</year><volume>36</volume><fpage>305</fpage><lpage>30</lpage></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Finney</surname><given-names>DL</given-names></name></person-group><source>Probit Analysis</source><year>1977</year><publisher-loc>New York</publisher-loc><publisher-name>Cambridge University Press</publisher-name><fpage>20</fpage></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keene</surname><given-names>AT</given-names></name><name><surname>Harris</surname><given-names>A</given-names></name><name><surname>Phillipson</surname><given-names>JD</given-names></name><name><surname>Warhurst</surname><given-names>DC</given-names></name></person-group><article-title><italic>In vitro</italic> amoebicidal testing of natural products: Part I. Methodology</article-title><source>Planta Med</source><year>1986</year><volume>4</volume><fpage>278</fpage><lpage>85</lpage></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calzada</surname><given-names>F</given-names></name><name><surname>Yepez-Mulia</surname><given-names>L</given-names></name><name><surname>Tapia-Contreras</surname><given-names>A</given-names></name><name><surname>Ortega</surname><given-names>A</given-names></name></person-group><article-title>Antiprotozoal and antibacterial properties of <italic>Decachaeta incompta</italic></article-title><source>Rev Latinoam Qu&#x000ed;m</source><year>2009</year><volume>37</volume><fpage>97</fpage><lpage>103</lpage></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calzada</surname><given-names>F</given-names></name><name><surname>Yepez-Mulia</surname><given-names>L</given-names></name><name><surname>Tapia-Contreras</surname><given-names>A</given-names></name><name><surname>Bautista</surname><given-names>E</given-names></name><name><surname>Maldonado</surname><given-names>E</given-names></name><name><surname>Ortega</surname><given-names>A</given-names></name></person-group><article-title>Evaluation of the antiprotozoal activity of neo-clerodane type diterpenes from <italic>Salvia polystachya</italic> against <italic>Entamoeba histolytica</italic> and <italic>Giardia lamblia</italic></article-title><source>Phytother Res</source><year>2010</year><volume>24</volume><fpage>662</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">19610033</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leitsch</surname><given-names>D</given-names></name><name><surname>Burgess</surname><given-names>AG</given-names></name><name><surname>Dunn</surname><given-names>LA</given-names></name><name><surname>Krauer</surname><given-names>KG</given-names></name><name><surname>Tan</surname><given-names>K</given-names></name><name><surname>Duch&#x000ea;ne</surname><given-names>M</given-names></name><etal/></person-group><article-title>Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in <italic>Giardia lamblia</italic></article-title><source>J Antimicrob Chemother</source><year>2011</year><volume>66</volume><fpage>1756</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">21602576</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlosser</surname><given-names>S</given-names></name><name><surname>Leitsch</surname><given-names>D</given-names></name><name><surname>Duch&#x000ea;ne</surname><given-names>M</given-names></name></person-group><article-title><italic>Entamoeba histolytica</italic>: Identification of thioredoxin-targeted proteins and analysis of serine acetyltransferase-1 as a prototype example</article-title><source>Biochem J</source><year>2013</year><volume>451</volume><fpage>277</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">23398389</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saavedra</surname><given-names>E</given-names></name><name><surname>Encalada</surname><given-names>R</given-names></name><name><surname>Pineda</surname><given-names>E</given-names></name><name><surname>Jasso-Ch&#x000e1;vez</surname><given-names>R</given-names></name><name><surname>Moreno-S&#x000e1;nchez</surname><given-names>R</given-names></name></person-group><article-title>Glycolysis in <italic>Entamoeba histolytica</italic>. Biochemical characterization of recombinant glycolytic enzymes and flux control analysis</article-title><source>FEBS J</source><year>2005</year><volume>272</volume><fpage>1767</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">15794763</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chabri&#x000e8;re</surname><given-names>E</given-names></name><name><surname>Charon</surname><given-names>MH</given-names></name><name><surname>Volbeda</surname><given-names>A</given-names></name><name><surname>Pieulle</surname><given-names>L</given-names></name><name><surname>Hatchikian</surname><given-names>EC</given-names></name><name><surname>Fontecilla-Camps</surname><given-names>JC</given-names></name></person-group><article-title>Crystal structures of the key anaerobic enzyme pyruvate:ferredoxin oxidoreductase, free and in complex with pyruvate</article-title><source>Nat Struct Biol</source><year>1999</year><volume>6</volume><fpage>182</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">10048931</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chabri&#x000e8;re</surname><given-names>E</given-names></name><name><surname>Vern&#x000e8;de</surname><given-names>X</given-names></name><name><surname>Guigliarelli</surname><given-names>B</given-names></name><name><surname>Charon</surname><given-names>MH</given-names></name><name><surname>Hatchikian</surname><given-names>EC</given-names></name><name><surname>Fontecilla-Camps</surname><given-names>JC</given-names></name></person-group><article-title>Crystal structure of the free radical intermediate of pyruvate:ferredoxin oxidoreductase</article-title><source>Science</source><year>2001</year><volume>294</volume><fpage>2559</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">11752578</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calzada</surname><given-names>F</given-names></name><name><surname>Meckes</surname><given-names>M</given-names></name><name><surname>Cedillo-Rivera</surname><given-names>R</given-names></name></person-group><article-title>Antiamoebic and antigiardial activity of plant flavonoids</article-title><source>Planta Med</source><year>1999</year><volume>65</volume><fpage>78</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">10083850</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>E</given-names></name><name><surname>Calzada</surname><given-names>F</given-names></name><name><surname>Campos</surname><given-names>R</given-names></name></person-group><article-title><italic>In vivo</italic> antigiardial activity of three flavonoids isolated of some medicinal plants used in Mexican traditional medicine for the treatment of diarrhea</article-title><source>J Ethnopharmacol</source><year>2007</year><volume>109</volume><fpage>552</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">17052875</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lozoya</surname><given-names>X</given-names></name><name><surname>Meckes</surname><given-names>M</given-names></name><name><surname>Abou-Zaid</surname><given-names>M</given-names></name><name><surname>Tortoriello</surname><given-names>J</given-names></name><name><surname>Nozzolillo</surname><given-names>C</given-names></name><name><surname>Arnason</surname><given-names>JT</given-names></name></person-group><article-title>Quercetin glycosides in <italic>Psidium guajava</italic> L. leaves and determination of a spasmolytic principle</article-title><source>Arch Med Res</source><year>1994</year><volume>25</volume><fpage>11</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8019108</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>AJ</given-names></name><name><surname>Dupont</surname><given-names>MS</given-names></name><name><surname>Ridley</surname><given-names>S</given-names></name><name><surname>Rhodes</surname><given-names>M</given-names></name><name><surname>Rhodes</surname><given-names>MJ</given-names></name><name><surname>Morgan</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity</article-title><source>FEBS Lett</source><year>1998</year><volume>436</volume><fpage>71</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">9771896</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Han</surname><given-names>MJ</given-names></name></person-group><article-title>Metabolism of quercitrin by human intestinal bacteria and its relation to some biological activities</article-title><source>Biol Pharm Bull</source><year>1999</year><volume>22</volume><fpage>749</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">10443478</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>NR</given-names></name><name><surname>Moon</surname><given-names>JS</given-names></name><name><surname>Shin</surname><given-names>SY</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>YB</given-names></name><name><surname>Kim</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Isolation and characterization of human intestinal <italic>Enterococcus avium</italic> EFEL009 converting rutin to quercetin</article-title><source>Lett Appl Microbiol</source><year>2016</year><volume>62</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">26505733</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bola&#x000f1;os</surname><given-names>V</given-names></name><name><surname>D&#x000ed;az-Mart&#x000ed;nez</surname><given-names>A</given-names></name><name><surname>Soto</surname><given-names>J</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>MA</given-names></name><name><surname>L&#x000f3;pez-Camarillo</surname><given-names>C</given-names></name><name><surname>Marchat</surname><given-names>LA</given-names></name><etal/></person-group><article-title>The flavonoid (-)-epicatechin affects cytoskeleton proteins and functions in <italic>Entamoeba histolytica</italic></article-title><source>J Proteomics</source><year>2014</year><volume>111</volume><fpage>74</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">24887480</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapetanovic</surname><given-names>IM</given-names></name></person-group><article-title>Computer-aided drug discovery and development (CADDD): <italic>In silico</italic>-chemico-biological approach</article-title><source>Chem Biol Interact</source><year>2008</year><volume>171</volume><fpage>165</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">17229415</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>H</given-names></name><name><surname>Bliznyuk</surname><given-names>AA</given-names></name><name><surname>Gready</surname><given-names>JE</given-names></name></person-group><article-title>Combining docking and molecular dynamic simulations in drug design</article-title><source>Med Res Rev</source><year>2006</year><volume>26</volume><fpage>531</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">16758486</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname><given-names>CH</given-names></name><name><surname>Fatima</surname><given-names>A</given-names></name><name><surname>Gaurav</surname><given-names>A</given-names></name></person-group><article-title><italic>In Silico</italic> investigation of flavonoids as potential trypanosomal nucleoside hydrolase inhibitors</article-title><source>Adv Bioinformatics</source><year>2015</year><volume>2015</volume><fpage>826047</fpage><pub-id pub-id-type="pmid">26640486</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galkin</surname><given-names>A</given-names></name><name><surname>Kulakova</surname><given-names>I</given-names></name><name><surname>Melamud</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Mariano</surname><given-names>P</given-names></name><etal/></person-group><article-title>Characterization, kinetics, and crystal structure of fructose-1, 6-bisphosphate aldolase from the human parasite, <italic>Giardia lamblia</italic></article-title><source>J Biol Chem</source><year>2007</year><volume>58</volume><fpage>7072</fpage><lpage>82</lpage></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Malik</surname><given-names>BK</given-names></name><name><surname>Sharma</surname><given-names>DK</given-names></name></person-group><article-title>Molecular modeling and docking analysis of <italic>Entamoeba histolytica</italic> glyceraldehyde-3 phosphate dehydrogenase, a potential target enzyme for anti-protozoal drug development</article-title><source>Chem Biol Drug Des</source><year>2008</year><volume>71</volume><fpage>554</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">18489439</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bola&#x000f1;os</surname><given-names>V</given-names></name><name><surname>D&#x000ed;az-Mart&#x000ed;nez</surname><given-names>A</given-names></name><name><surname>Soto</surname><given-names>J</given-names></name><name><surname>Marchat</surname><given-names>LA</given-names></name><name><surname>Sanchez-Monroy</surname><given-names>V</given-names></name><name><surname>Ram&#x000ed;rez-Moreno</surname><given-names>E</given-names></name></person-group><article-title>Kaempferol inhibits <italic>Entamoeba histolytica</italic> growth by altering cytoskeletal functions</article-title><source>Mol Biochem Parasitol</source><year>2015</year><volume>204</volume><fpage>16</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">26620675</pub-id></element-citation></ref></ref-list></back></article>